Massachusetts Devicemaker Hit for Discrepancy Investigation Reports

The FDA cited Acorda Therapeutics’ Chelsea, Massachusetts manufacturing facility for its handling of discrepancy investigations observed during a June 4-18, 2018 inspection.
Source: The GMP Letter